Clinical trial
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or…
NCT00380575 · Cumberland Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00380575 |
|---|---|
| Title | Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia |
| Official title | A 4-Day, Double-Blind, Placebo-Controlled, Multicenter Study of IV YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia |
| Lead sponsor | Cumberland Pharmaceuticals, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyponatremia |
| Intervention type | Drug |
| Interventions | YM087 |
| Enrollment | 84 |
| Start date | Aug 1, 2000 |
| Completion | Feb 1, 2003 |
| First posted | Sep 26, 2006 |
| Last update posted | May 2, 2014 |
| Countries | Canada, Israel, South Africa, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: